Energy metabolism in the liver.

The liver is an essential metabolic organ, and its metabolic function is controlled by insulin and other metabolic hormones. Glucose is converted into pyruvate through glycolysis in the cytoplasm, and pyruvate is subsequently oxidized in the mitochondria to generate ATP through the TCA cycle and oxidative phosphorylation. In the fed state, glycolytic products are used to synthesize fatty acids through de novo lipogenesis. Long-chain fatty acids are incorporated into triacylglycerol, phospholipids, and/or cholesterol esters in hepatocytes. These complex lipids are stored in lipid droplets and membrane structures, or secreted into the circulation as very low-density lipoprotein particles. In the fasted state, the liver secretes glucose through both glycogenolysis and gluconeogenesis. During pronged fasting, hepatic gluconeogenesis is the primary source for endogenous glucose production. Fasting also promotes lipolysis in adipose tissue, resulting in release of nonesterified fatty acids which are converted into ketone bodies in hepatic mitochondria though β-oxidation and ketogenesis. Ketone bodies provide a metabolic fuel for extrahepatic tissues. Liver energy metabolism is tightly regulated by neuronal and hormonal signals. The sympathetic system stimulates, whereas the parasympathetic system suppresses, hepatic gluconeogenesis. Insulin stimulates glycolysis and lipogenesis but suppresses gluconeogenesis, and glucagon counteracts insulin action. Numerous transcription factors and coactivators, including CREB, FOXO1, ChREBP, SREBP, PGC-1α, and CRTC2, control the expression of the enzymes which catalyze key steps of metabolic pathways, thus controlling liver energy metabolism. Aberrant energy metabolism in the liver promotes insulin resistance, diabetes, and nonalcoholic fatty liver diseases.

[1]  P. Scherer,et al.  An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. , 2013, Cell metabolism.

[2]  S. Bornstein,et al.  Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice. , 2013, Cell metabolism.

[3]  G. Hotamisligil,et al.  Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production. , 2013, Cell metabolism.

[4]  S. Woods,et al.  Fibroblast Growth Factor 21 Mediates Specific Glucagon Actions , 2013, Diabetes.

[5]  A. Moschetta,et al.  Hepatic‐specific activation of peroxisome proliferator‐activated receptor γ coactivator‐1β protects against steatohepatitis , 2013, Hepatology.

[6]  F. Schütz,et al.  Hepatic glucose sensing is required to preserve β cell glucose competence. , 2013, The Journal of clinical investigation.

[7]  B. Staels,et al.  Farnesoid X Receptor Inhibits the Transcriptional Activity of Carbohydrate Response Element Binding Protein in Human Hepatocytes , 2013, Molecular and Cellular Biology.

[8]  G. Ning,et al.  Yin Yang 1 Promotes Hepatic Gluconeogenesis Through Upregulation of Glucocorticoid Receptor , 2013, Diabetes.

[9]  S. Young,et al.  Biochemistry and pathophysiology of intravascular and intracellular lipolysis. , 2013, Genes & development.

[10]  Kristopher J. Stanya,et al.  Direct control of hepatic glucose production by interleukin-13 in mice. , 2013, The Journal of clinical investigation.

[11]  A. Pfeiffer,et al.  Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis? , 2013, Diabetologia.

[12]  R. Matsumori,et al.  Elovl6 promotes nonalcoholic steatohepatitis , 2012, Hepatology.

[13]  G. Calamita,et al.  Aquaporin-9 and urea transporter-A gene deletions affect urea transmembrane passage in murine hepatocytes. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[14]  G. Sumara,et al.  Gut-derived serotonin is a multifunctional determinant to fasting adaptation. , 2012, Cell metabolism.

[15]  L. Glimcher,et al.  Silencing of lipid metabolism genes through IRE1α-mediated mRNA decay lowers plasma lipids in mice. , 2012, Cell metabolism.

[16]  H. R. Payne,et al.  Loss of intracellular lipid binding proteins differentially impacts saturated fatty acid uptake and nuclear targeting in mouse hepatocytes. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[17]  In-kyu Lee,et al.  Transcriptional Regulation of Pyruvate Dehydrogenase Kinase , 2012, Diabetes & metabolism journal.

[18]  R. Moriggl,et al.  Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer development , 2012, Molecular and Cellular Endocrinology.

[19]  In-kyu Lee,et al.  Orphan Nuclear Receptor Small Heterodimer Partner Negatively Regulates Growth Hormone-mediated Induction of Hepatic Gluconeogenesis through Inhibition of Signal Transducer and Activator of Transcription 5 (STAT5) Transactivation* , 2012, The Journal of Biological Chemistry.

[20]  J. Seong,et al.  Nuclear receptor PPARγ-regulated monoacylglycerol O-acyltransferase 1 (MGAT1) expression is responsible for the lipid accumulation in diet-induced hepatic steatosis , 2012, Proceedings of the National Academy of Sciences.

[21]  J. Kirwan,et al.  Role of ceramides in nonalcoholic fatty liver disease , 2012, Trends in Endocrinology & Metabolism.

[22]  S. Mukhopadhyay,et al.  Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance , 2012, Nature Medicine.

[23]  J. Auwerx,et al.  LRH-1-dependent glucose sensing determines intermediary metabolism in liver. , 2012, The Journal of clinical investigation.

[24]  K. Siminovitch,et al.  Hepatocyte-Specific Ptpn6 Deletion Protects From Obesity-Linked Hepatic Insulin Resistance , 2012, Diabetes.

[25]  H. Guillou,et al.  The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. , 2012, The Journal of clinical investigation.

[26]  L. Rui,et al.  NF-κB-inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action , 2012, Nature Medicine.

[27]  J. Yates,et al.  Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity. , 2012, Cell metabolism.

[28]  M. Hall,et al.  Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. , 2012, Cell metabolism.

[29]  G. Shulman,et al.  Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance. , 2012, Cell metabolism.

[30]  Jiandie D. Lin,et al.  Ubiquitin-Specific Protease 2 Regulates Hepatic Gluconeogenesis and Diurnal Glucose Metabolism Through 11β-Hydroxysteroid Dehydrogenase 1 , 2012, Diabetes.

[31]  K. Murao,et al.  Liver X Receptor α Is Involved in the Transcriptional Regulation of the 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase Gene , 2012, Diabetes.

[32]  Logan J Everett,et al.  Rev-erbα and Rev-erbβ coordinately protect the circadian clock and normal metabolic function. , 2012, Genes & development.

[33]  Z. Al-Oanzi,et al.  Fructose 2,6-bisphosphate is essential for glucose-regulated gene transcription of glucose-6-phosphatase and other ChREBP target genes in hepatocytes. , 2012, The Biochemical journal.

[34]  Tomoshige Kino,et al.  Liver X Receptors Regulate the Transcriptional Activity of the Glucocorticoid Receptor: Implications for the Carbohydrate Metabolism , 2012, PloS one.

[35]  P. Tontonoz,et al.  Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR , 2012, Nature Reviews Molecular Cell Biology.

[36]  Hongyu Zhao,et al.  Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents , 2012, Hepatology.

[37]  R. Coppari,et al.  Direct leptin action on POMC neurons regulates glucose homeostasis and hepatic insulin sensitivity in mice. , 2012, The Journal of clinical investigation.

[38]  G. Mitchell,et al.  Fasting energy homeostasis in mice with adipose deficiency of desnutrin/adipose triglyceride lipase. , 2012, Endocrinology.

[39]  L. Rui,et al.  Hepatic TRAF2 Regulates Glucose Metabolism Through Enhancing Glucagon Responses , 2012, Diabetes.

[40]  V. Koteliansky,et al.  The Scap/SREBP pathway is essential for developing diabetic fatty liver and carbohydrate-induced hypertriglyceridemia in animals. , 2012, Cell metabolism.

[41]  C. Kahn,et al.  Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1 , 2012, Nature Medicine.

[42]  Jiansheng Huang,et al.  Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  R. DePinho,et al.  Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice. , 2012, Endocrinology.

[44]  L. Cebotaru,et al.  C1q/TNF-related Protein-12 (CTRP12), a Novel Adipokine That Improves Insulin Sensitivity and Glycemic Control in Mouse Models of Obesity and Diabetes* , 2012, The Journal of Biological Chemistry.

[45]  Tim C. Roloff,et al.  Histone Deacetylase 6 (HDAC6) Is an Essential Modifier of Glucocorticoid-Induced Hepatic Gluconeogenesis , 2012, Diabetes.

[46]  Richard A. Flavell,et al.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity , 2012, Nature.

[47]  Y. Xiong,et al.  Acetylation negatively regulates glycogen phosphorylase by recruiting protein phosphatase 1. , 2012, Cell metabolism.

[48]  A. Cherrington,et al.  Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover. , 2012, The Journal of clinical investigation.

[49]  E. Oetjen Hepatic Glucagon Action Is Essential for Exercise-Induced Reversal of Mouse Fatty Liver , 2012 .

[50]  J. Girard,et al.  Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liver. , 2012, Journal of hepatology.

[51]  Robert A. Harris,et al.  Metformin Inhibits Growth Hormone – Mediated Hepatic Pyruvate Dehydrogenase Kinase 4 Gene Expression Through Induction of Orphan Nuclear Receptor Small Heterodimer Partner , 2012 .

[52]  J. Bryan,et al.  Hypothalamic Leucine Metabolism Regulates Liver Glucose Production , 2011, Diabetes.

[53]  S. Burgess,et al.  Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. , 2011, Cell metabolism.

[54]  F. Alemi,et al.  Impairment of central leptin-mediated PI3K signaling manifested as hepatic steatosis independent of hyperphagia and obesity. , 2011, Cell metabolism.

[55]  T. Shioda,et al.  A Conserved SREBP-1/Phosphatidylcholine Feedback Circuit Regulates Lipogenesis in Metazoans , 2011, Cell.

[56]  R. Evans,et al.  Cryptochromes mediate rhythmic repression of the glucocorticoid receptor , 2011, Nature.

[57]  C. Palmeira,et al.  Hepatic FXR: key regulator of whole-body energy metabolism , 2011, Trends in Endocrinology & Metabolism.

[58]  C. Deng,et al.  Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance. , 2011, The Journal of clinical investigation.

[59]  S. Ringquist,et al.  FoxO6 Integrates Insulin Signaling With Gluconeogenesis in the Liver , 2011, Diabetes.

[60]  K. Kaestner,et al.  Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP1c. , 2011, Cell metabolism.

[61]  R. Zarnegar,et al.  A Hepatocyte Growth Factor Receptor (Met)–Insulin Receptor hybrid governs hepatic glucose metabolism , 2011, Nature Medicine.

[62]  Yong Liu,et al.  PKA phosphorylation couples hepatic inositol-requiring enzyme 1α to glucagon signaling in glucose metabolism , 2011, Proceedings of the National Academy of Sciences.

[63]  A. Mari,et al.  Brain insulin action augments hepatic glycogen synthesis without suppressing glucose production or gluconeogenesis in dogs. , 2011, The Journal of clinical investigation.

[64]  D. Green,et al.  Disrupting the CH1 domain structure in the acetyltransferases CBP and p300 results in lean mice with increased metabolic control. , 2011, Cell metabolism.

[65]  Y. Barak,et al.  Role for PPARγ in obesity‐induced hepatic steatosis as determined by hepatocyte‐ and macrophage‐specific conditional knockouts , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[66]  Anne E Carpenter,et al.  mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway , 2011, Cell.

[67]  Y. Xiong,et al.  Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBR5 ubiquitin ligase. , 2011, Molecular cell.

[68]  Derek W. Yecies,et al.  Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. , 2011, Cell metabolism.

[69]  R. Hegele,et al.  The transcription factor cyclic AMP–responsive element–binding protein H regulates triglyceride metabolism , 2011, Nature Medicine.

[70]  Scott A. Busby,et al.  A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects , 2011, Nature.

[71]  B. Spiegelman,et al.  Separation of the gluconeogenic and mitochondrial functions of PGC-1{alpha} through S6 kinase. , 2011, Genes & development.

[72]  S. Kliewer,et al.  FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1α pathway. , 2011, Cell metabolism.

[73]  R. Coleman,et al.  The role of lipid droplets in metabolic disease in rodents and humans. , 2011, The Journal of clinical investigation.

[74]  R. Evans,et al.  Class IIa Histone Deacetylases Are Hormone-Activated Regulators of FOXO and Mammalian Glucose Homeostasis , 2011, Cell.

[75]  Mengwei Zang,et al.  AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. , 2011, Cell metabolism.

[76]  W. Wahli,et al.  Hepatic deficiency in transcriptional cofactor TBL1 promotes liver steatosis and hypertriglyceridemia. , 2011, Cell metabolism.

[77]  Xiaoyong Yang,et al.  O-GlcNAcylation Increases ChREBP Protein Content and Transcriptional Activity in the Liver , 2011, Diabetes.

[78]  B. Sos,et al.  Abrogation of growth hormone secretion rescues fatty liver in mice with hepatocyte-specific deletion of JAK2. , 2011, The Journal of clinical investigation.

[79]  Hui-yu Liu,et al.  Constitutive role for IRE1α-XBP1 signaling pathway in the insulin-mediated hepatic lipogenic program. , 2011, Endocrinology.

[80]  S. Kliewer,et al.  FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis , 2011, Science.

[81]  Tao Liu,et al.  A Circadian Rhythm Orchestrated by Histone Deacetylase 3 Controls Hepatic Lipid Metabolism , 2011, Science.

[82]  M. White,et al.  Regulation of glucose homeostasis through a XBP-1–FoxO1 interaction , 2011, Nature Medicine.

[83]  F. Pilleul,et al.  Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas. , 2011, Journal of hepatology.

[84]  O. Gavrilova,et al.  Wnt Signaling Regulates Hepatic Metabolism , 2011, Science Signaling.

[85]  M. White,et al.  Feedback regulation of hepatic gluconeogenesis through modulation of SHP/Nr0b2 gene expression by Sirt1 and FoxO1. , 2011, American journal of physiology. Endocrinology and metabolism.

[86]  Lloyd M. Smith,et al.  Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction. , 2011, Molecular cell.

[87]  M. J. Charron,et al.  Glucagon Receptor Knockout Prevents Insulin-Deficient Type 1 Diabetes in Mice , 2011, Diabetes.

[88]  A. Bookout,et al.  LXRβ is required for glucocorticoid-induced hyperglycemia and hepatosteatosis in mice. , 2011, The Journal of clinical investigation.

[89]  K. Adeli,et al.  C‐reactive protein impairs hepatic insulin sensitivity and insulin signaling in rats: Role of mitogen‐activated protein kinases , 2011, Hepatology.

[90]  D. Sabatini,et al.  mTORC1 controls fasting-induced ketogenesis and its modulation by ageing , 2010, Nature.

[91]  F. Alt,et al.  SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. , 2010, Cell metabolism.

[92]  J. Girard,et al.  Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice. , 2010, The Journal of clinical investigation.

[93]  P. Saha,et al.  The coactivator SRC-1 is an essential coordinator of hepatic glucose production. , 2010, Cell metabolism.

[94]  J. Balschi,et al.  Role of Peroxisome Proliferator-activated Receptor δ/β in Hepatic Metabolic Regulation* , 2010, The Journal of Biological Chemistry.

[95]  D. Mashek,et al.  Hepatic long-chain acyl-CoA synthetase 5 mediates fatty acid channeling between anabolic and catabolic pathways[S] , 2010, Journal of Lipid Research.

[96]  Yaohui Nie,et al.  MAPK phosphatase-3 promotes hepatic gluconeogenesis through dephosphorylation of forkhead box O1 in mice. , 2010, The Journal of clinical investigation.

[97]  R. Kaufman,et al.  The unfolded protein response is required to maintain the integrity of the endoplasmic reticulum, prevent oxidative stress and preserve differentiation in β-cells , 2010, Diabetes, obesity & metabolism.

[98]  K. Kaestner,et al.  FoxOs Function Synergistically to Promote Glucose Production* , 2010, The Journal of Biological Chemistry.

[99]  Xiaoling Xu,et al.  Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. , 2010, Cell metabolism.

[100]  T. Veenstra,et al.  SIRT1 Deacetylates and Inhibits SREBP-1C Activity in Regulation of Hepatic Lipid Metabolism* , 2010, The Journal of Biological Chemistry.

[101]  M. Kay,et al.  FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase. , 2010, American journal of physiology. Endocrinology and metabolism.

[102]  Dmitri A. Nusinow,et al.  Cryptochrome Mediates Circadian Regulation of cAMP Signaling and Hepatic Gluconeogenesis , 2010, Nature Medicine.

[103]  Min Jae Lee,et al.  A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis. , 2010, Gastroenterology.

[104]  Aidan S. Hancock,et al.  Glucagon deficiency reduces hepatic glucose production and improves glucose tolerance in adult mice. , 2010, Molecular endocrinology.

[105]  P. Puigserver,et al.  Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP. , 2010, Genes & development.

[106]  Young-sil Yoon,et al.  Regulation of hepatic gluconeogenesis by an ER-bound transcription factor, CREBH. , 2010, Cell metabolism.

[107]  A. Viale,et al.  Identification of neuronal subpopulations that project from hypothalamus to both liver and adipose tissue polysynaptically , 2010, Proceedings of the National Academy of Sciences.

[108]  Xin Lu,et al.  The G(0)/G(1) switch gene 2 regulates adipose lipolysis through association with adipose triglyceride lipase. , 2010, Cell metabolism.

[109]  Yixue Li,et al.  Regulation of Cellular Metabolism by Protein Lysine Acetylation , 2010, Science.

[110]  Shijie Li,et al.  Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis , 2010, Proceedings of the National Academy of Sciences.

[111]  G. Gores,et al.  Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice. , 2010, The Journal of clinical investigation.

[112]  M. Montminy,et al.  Targeted disruption of the CREB coactivator Crtc2 increases insulin sensitivity , 2010, Proceedings of the National Academy of Sciences.

[113]  Robert V Farese,et al.  SIRT 3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation , 2010 .

[114]  S. Mohanty,et al.  Nonalcoholic Fatty Liver Disease: A Review and Update , 2010, Digestive Diseases and Sciences.

[115]  G. Shulman,et al.  Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding protein. , 2009, Cell metabolism.

[116]  A. Mora,et al.  Prevention of steatosis by hepatic JNK1. , 2009, Cell metabolism.

[117]  L. Rui,et al.  Recent advances in understanding leptin signaling and leptin resistance. , 2009, American journal of physiology. Endocrinology and metabolism.

[118]  J. Dubé,et al.  Depletion of Liver Kupffer Cells Prevents the Development of Diet-Induced Hepatic Steatosis and Insulin Resistance , 2009, Diabetes.

[119]  T. Veenstra,et al.  FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states. , 2009, Cell metabolism.

[120]  J. Granneman,et al.  Perilipin Controls Lipolysis by Regulating the Interactions of AB-hydrolase Containing 5 (Abhd5) and Adipose Triglyceride Lipase (Atgl)* , 2009, The Journal of Biological Chemistry.

[121]  L. Sanderson,et al.  Peroxisome Proliferator-Activated Receptor β/δ (PPARβ/δ) but Not PPARα Serves as a Plasma Free Fatty Acid Sensor in Liver , 2009, Molecular and Cellular Biology.

[122]  S. Bischoff,et al.  Toll‐like receptor 4 is involved in the development of fructose‐induced hepatic steatosis in mice , 2009, Hepatology.

[123]  John Turk,et al.  Identification of a Physiologically Relevant Endogenous Ligand for PPARα in Liver , 2009, Cell.

[124]  T. Lam,et al.  Intestinal cholecystokinin controls glucose production through a neuronal network. , 2009, Cell metabolism.

[125]  Shuli Wang,et al.  Liver-specific Loss of Long Chain Acyl-CoA Synthetase-1 Decreases Triacylglycerol Synthesis and β-Oxidation and Alters Phospholipid Fatty Acid Composition* , 2009, The Journal of Biological Chemistry.

[126]  Sunmin Park,et al.  The Irs1 Branch of the Insulin Signaling Cascade Plays a Dominant Role in Hepatic Nutrient Homeostasis , 2009, Molecular and Cellular Biology.

[127]  G. Tuteja,et al.  CRTC2 (TORC2) contributes to the transcriptional response to fasting in the liver but is not required for the maintenance of glucose homeostasis. , 2009, Cell metabolism.

[128]  M. Gillum,et al.  SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats , 2009, Proceedings of the National Academy of Sciences.

[129]  G. Baffy Kupffer cells in non-alcoholic fatty liver disease: the emerging view. , 2009, Journal of hepatology.

[130]  S. Kliewer,et al.  FGF21 induces PGC-1α and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response , 2009, Proceedings of the National Academy of Sciences.

[131]  L. Rui,et al.  SH2B1 Enhances Insulin Sensitivity by Both Stimulating the Insulin Receptor and Inhibiting Tyrosine Dephosphorylation of Insulin Receptor Substrate Proteins , 2009, Diabetes.

[132]  A. Hollenberg,et al.  STAT3 targets the regulatory regions of gluconeogenic genes in vivo. , 2009, Molecular endocrinology.

[133]  T. Clemens,et al.  Liver-specific Deletion of the Growth Hormone Receptor Reveals Essential Role of Growth Hormone Signaling in Hepatic Lipid Metabolism*♦ , 2009, The Journal of Biological Chemistry.

[134]  F. Wondisford,et al.  Metformin and Insulin Suppress Hepatic Gluconeogenesis through Phosphorylation of CREB Binding Protein , 2009, Cell.

[135]  M. Montminy,et al.  The CREB Coactivator CRTC2 Links Hepatic ER Stress and Fasting Gluconeogenesis , 2009, Nature.

[136]  S. Luquet,et al.  GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. , 2009, The Journal of clinical investigation.

[137]  Takashi Nakagawa,et al.  SIRT5 Deacetylates Carbamoyl Phosphate Synthetase 1 and Regulates the Urea Cycle , 2009, Cell.

[138]  Sushant Bhatnagar,et al.  Fibroblast Growth Factor-19, a Novel Factor That Inhibits Hepatic Fatty Acid Synthesis* , 2009, Journal of Biological Chemistry.

[139]  Qing Xu,et al.  Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. , 2009, Cell metabolism.

[140]  M. Dietrich,et al.  STAT3 inhibition of gluconeogenesis is downregulated by SirT1 , 2009, Nature Cell Biology.

[141]  Hei Sook Sul,et al.  A Role of DNA-PK for the Metabolic Gene Regulation in Response to Insulin , 2009, Cell.

[142]  G. Shulman,et al.  The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance. , 2009, Cell metabolism.

[143]  B. Neel,et al.  Liver-Specific Deletion of Protein-Tyrosine Phosphatase 1B (PTP1B) Improves Metabolic Syndrome and Attenuates Diet-Induced Endoplasmic Reticulum Stress , 2009, Diabetes.

[144]  R. Printz,et al.  Restoration of Hepatic Glucokinase Expression Corrects Hepatic Glucose Flux and Normalizes Plasma Glucose in Zucker Diabetic Fatty Rats , 2009, Diabetes.

[145]  Masahito Watanabe,et al.  IN MICE , 2009 .

[146]  M. Katze,et al.  UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators. , 2008, Developmental cell.

[147]  A. Mora,et al.  A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance , 2008, Science.

[148]  S. Najjar,et al.  Development of nonalcoholic steatohepatitis in insulin-resistant liver-specific S503A carcinoembryonic antigen-related cell adhesion molecule 1 mutant mice. , 2008, Gastroenterology.

[149]  P. Saha,et al.  Absence of the SRC-2 Coactivator Results in a Glycogenopathy Resembling Von Gierke's Disease , 2008, Science.

[150]  D. Drucker,et al.  The Glucagon Receptor Is Required for the Adaptive Metabolic Response to Fasting , 2022 .

[151]  S. Watkins,et al.  Identification of a Lipokine, a Lipid Hormone Linking Adipose Tissue to Systemic Metabolism , 2008, Cell.

[152]  J. Yates,et al.  A Fasting Inducible Switch Modulates Gluconeogenesis Via Activator-Coactivator Exchange , 2008, Nature.

[153]  K. Gardner,et al.  Regulation of Nuclear Import/Export of Carbohydrate Response Element-binding Protein (ChREBP) , 2008, Journal of Biological Chemistry.

[154]  U. Klingmüller,et al.  The glucocorticoid receptor controls hepatic dyslipidemia through Hes1. , 2008, Cell metabolism.

[155]  R. Kulkarni,et al.  Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 , 2008, Diabetes.

[156]  L. Agius Glucokinase and molecular aspects of liver glycogen metabolism. , 2008, The Biochemical journal.

[157]  Jiandie D. Lin,et al.  Genome-wide coactivation analysis of PGC-1alpha identifies BAF60a as a regulator of hepatic lipid metabolism. , 2008, Cell metabolism.

[158]  R. DePinho,et al.  Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation. , 2008, Cell metabolism.

[159]  S. Kliewer,et al.  Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. , 2008, Cell metabolism.

[160]  F. Alt,et al.  Tissue-specific regulation of SIRT1 by calorie restriction. , 2008, Genes & development.

[161]  Robert A. Harris,et al.  Pyruvate dehydrogenase kinase-4 deficiency lowers blood glucose and improves glucose tolerance in diet-induced obese mice. , 2008, American journal of physiology. Endocrinology and metabolism.

[162]  L. Glimcher,et al.  Regulation of Hepatic Lipogenesis by the Transcription Factor XBP1 , 2008, Science.

[163]  A. DeAngelis CEACAM1: A Link Between Insulin and Lipid Metabolism , 2008 .

[164]  D. Ron,et al.  Dephosphorylation of translation initiation factor 2alpha enhances glucose tolerance and attenuates hepatosteatosis in mice. , 2008, Cell metabolism.

[165]  A. Chawla,et al.  Cidea is associated with lipid droplets and insulin sensitivity in humans , 2008, Proceedings of the National Academy of Sciences.

[166]  P. Light,et al.  Upper intestinal lipids trigger a gut–brain–liver axis to regulate glucose production , 2008, Nature.

[167]  F. Gonzalez,et al.  Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27. , 2008, Cell metabolism.

[168]  S. Hiebert,et al.  Liver‐specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks , 2008, The EMBO journal.

[169]  Pascale Bossard,et al.  ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver. , 2008, The Journal of clinical investigation.

[170]  J. Qin,et al.  Negative regulation of the deacetylase SIRT1 by DBC1 , 2008, Nature.

[171]  Junjie Chen,et al.  DBC1 is a negative regulator of SIRT1 , 2008, Nature.

[172]  M. Miyazaki,et al.  Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis. , 2007, Cell metabolism.

[173]  G. Shulman,et al.  Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance , 2007, Proceedings of the National Academy of Sciences.

[174]  J. Yates,et al.  Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. , 2007, Nature.

[175]  S. Herzig,et al.  Glucocorticoids, metabolism and metabolic diseases , 2007, Molecular and Cellular Endocrinology.

[176]  R. DePinho,et al.  Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. , 2007, Cell metabolism.

[177]  A. Fukamizu,et al.  Foxo1 links insulin signaling to C/EBPα and regulates gluconeogenesis during liver development , 2007, The EMBO journal.

[178]  L. Hennighausen,et al.  Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration , 2007, Hepatology.

[179]  P. Puigserver,et al.  Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1 , 2007, Proceedings of the National Academy of Sciences.

[180]  M. Birnbaum,et al.  Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1α transcription coactivator , 2007, Nature.

[181]  F. Ashcroft,et al.  Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production. , 2007, Cell metabolism.

[182]  J. Flier,et al.  Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. , 2007, Cell metabolism.

[183]  S. Kliewer,et al.  Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. , 2007, Cell metabolism.

[184]  R. Eckel,et al.  CCAAT/Enhancer-binding Protein β Deletion Reduces Adiposity, Hepatic Steatosis, and Diabetes in Leprdb/db Mice* , 2007, Journal of Biological Chemistry.

[185]  B. Lowell,et al.  Synaptic glutamate release by ventromedial hypothalamic neurons is part of the neurocircuitry that prevents hypoglycemia. , 2007, Cell metabolism.

[186]  Jill M. Schroeder-Gloeckler,et al.  CCAAT/enhancing binding protein β deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet‐induced nonalcoholic steatohepatitis , 2007, Hepatology.

[187]  Minghua Li,et al.  Neuronal SH2B1 is essential for controlling energy and glucose homeostasis. , 2007, The Journal of clinical investigation.

[188]  P. Tso,et al.  Brain glucose metabolism controls the hepatic secretion of triglyceride-rich lipoproteins , 2007, Nature Medicine.

[189]  K. Ohbuchi,et al.  Hepatic De Novo Lipogenesis Is Present in Liver-Specific ACC1-Deficient Mice , 2007, Molecular and Cellular Biology.

[190]  J. Cha,et al.  The Liver X Receptor (LXR) and Hepatic Lipogenesis , 2007, Journal of Biological Chemistry.

[191]  B. Thiers Genomic Instability and Aging-like Phenotype in the Absence of Mammalian SIRT6 , 2007 .

[192]  R. Eckel,et al.  CCAAT/enhancer-binding protein beta deletion reduces adiposity, hepatic steatosis, and diabetes in Lepr(db/db) mice. , 2007, The Journal of biological chemistry.

[193]  D. Russell,et al.  Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice. , 2007, Cell metabolism.

[194]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[195]  T. Osborne,et al.  Coordinated control of bile acids and lipogenesis through FXR-dependent regulation of fatty acid synthase1 Published, JLR Papers in Press, September 6, 2006. , 2006, Journal of Lipid Research.

[196]  M. J. Charron,et al.  Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia , 2006, Diabetologia.

[197]  S. Kennedy,et al.  Protection against Western diet–induced obesity and hepatic steatosis in liver fatty acid–binding protein knockout mice , 2006, Hepatology.

[198]  J. Flier,et al.  TLR4 links innate immunity and fatty acid-induced insulin resistance. , 2006, The Journal of clinical investigation.

[199]  J. Qin,et al.  SIN1/MIP1 Maintains rictor-mTOR Complex Integrity and Regulates Akt Phosphorylation and Substrate Specificity , 2006, Cell.

[200]  T. Harris,et al.  Lipin 1 is an inducible amplifier of the hepatic PGC-1α/PPARα regulatory pathway , 2006 .

[201]  J. Girard,et al.  Liver-Specific Inhibition of ChREBP Improves Hepatic Steatosis and Insulin Resistance in ob/ob Mice , 2006, Diabetes.

[202]  J. Repa,et al.  Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. , 2006, Cell metabolism.

[203]  Robert A. Harris,et al.  Role of pyruvate dehydrogenase kinase isoenzyme 4 (PDHK4) in glucose homoeostasis during starvation. , 2006, The Biochemical journal.

[204]  K. Iizuka,et al.  Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob/ob) mice. , 2006, American journal of physiology. Endocrinology and metabolism.

[205]  T. Friedman,et al.  Liver X receptor agonist T0901317 inhibition of glucocorticoid receptor expression in hepatocytes may contribute to the amelioration of diabetic syndrome in db/db mice. , 2006, Endocrinology.

[206]  A. M. Etgen,et al.  Critical role of STAT3 in leptin's metabolic actions. , 2006, Cell metabolism.

[207]  P. Puigserver,et al.  GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1alpha. , 2006, Cell metabolism.

[208]  Ziwei Gu,et al.  Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[209]  R. Evans,et al.  A Novel Pregnane X Receptor-mediated and Sterol Regulatory Element-binding Protein-independent Lipogenic Pathway* , 2006, Journal of Biological Chemistry.

[210]  B. Viollet,et al.  Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin. , 2006, Endocrinology.

[211]  Petra C. Kienesberger,et al.  Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome. , 2006, Cell metabolism.

[212]  Janardan K Reddy,et al.  Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[213]  S. Akira,et al.  Role of hepatic STAT3 in brain-insulin action on hepatic glucose production. , 2006, Cell metabolism.

[214]  R. Gimeno,et al.  Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis. , 2006, Gastroenterology.

[215]  G. Shulman,et al.  Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. , 2006, The Journal of clinical investigation.

[216]  Timothy M Willson,et al.  Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[217]  Xueying Lin,et al.  Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth. , 2006, The Journal of clinical investigation.

[218]  T. Harris,et al.  Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway. , 2006, Cell metabolism.

[219]  T. Becker,et al.  p38 Mitogen-activated Protein Kinase Plays a Stimulatory Role in Hepatic Gluconeogenesis* , 2005, Journal of Biological Chemistry.

[220]  R. DePinho,et al.  The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin , 2005, Science.

[221]  O. Gavrilova,et al.  Increased glucose tolerance and reduced adiposity in the absence of fasting hypoglycemia in mice with liver-specific Gs alpha deficiency. , 2005, The Journal of clinical investigation.

[222]  M. Montminy,et al.  The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism , 2005, Nature.

[223]  S. Kliewer,et al.  Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. , 2005, Cell metabolism.

[224]  Ziwei Gu,et al.  Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[225]  A. Fukamizu,et al.  Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[226]  A. Pocai,et al.  Regulation of Blood Glucose by Hypothalamic Pyruvate Metabolism , 2005, Science.

[227]  Minghua Li,et al.  Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice. , 2005, Cell metabolism.

[228]  Tiffany A. Miller,et al.  Insulin acutely decreases hepatic fatty acid synthase activity. , 2005, Cell metabolism.

[229]  Minoru Yoshida,et al.  HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. , 2005, Molecular cell.

[230]  J. Jessurun,et al.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.

[231]  J. Schneider,et al.  "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. , 2005, Cell metabolism.

[232]  Wilhelm Haas,et al.  Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1 , 2005, Nature.

[233]  J. Bryan,et al.  Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis , 2005, Nature Medicine.

[234]  S. Shoelson,et al.  Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB , 2005, Nature Medicine.

[235]  Christoph Handschin,et al.  Hyperlipidemic Effects of Dietary Saturated Fats Mediated through PGC-1β Coactivation of SREBP , 2005, Cell.

[236]  A. Hevener,et al.  IKK-beta links inflammation to obesity-induced insulin resistance. , 2005, Nature medicine.

[237]  S. Shoelson,et al.  Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. , 2005, Nature medicine.

[238]  Craig R Malloy,et al.  Impaired Tricarboxylic Acid Cycle Activity in Mouse Livers Lacking Cytosolic Phosphoenolpyruvate Carboxykinase* , 2004, Journal of Biological Chemistry.

[239]  Yusuke Inoue,et al.  Disruption of Hepatic C/EBPα Results in Impaired Glucose Tolerance and Age-dependent Hepatosteatosis* , 2004, Journal of Biological Chemistry.

[240]  L. Glimcher,et al.  Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes , 2004, Science.

[241]  Minghua Li,et al.  SH2-B Promotes Insulin Receptor Substrate 1 (IRS1)- and IRS2-mediated Activation of the Phosphatidylinositol 3-Kinase Pathway in Response to Leptin* , 2004, Journal of Biological Chemistry.

[242]  M. White,et al.  Disruption of the SH2-B Gene Causes Age-Dependent Insulin Resistance and Glucose Intolerance , 2004, Molecular and Cellular Biology.

[243]  Guoxun Chen,et al.  Trace: Tennessee Research and Creative Exchange Nutrition Publications and Other Works Nutrition Central Role for Liver X Receptor in Insulin-mediated Activation of Srebp-1c Transcription and Stimulation of Fatty Acid Synthesis in Liver. Recommended Citation , 2022 .

[244]  D. Vertommen,et al.  6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis. , 2004, The Biochemical journal.

[245]  Alexandre Reymond,et al.  The subcellular localization of the ChoRE-binding protein, encoded by the Williams-Beuren syndrome critical region gene 14, is regulated by 14-3-3. , 2004, Human molecular genetics.

[246]  C. Kahn,et al.  Suppressor of Cytokine Signaling 1 (SOCS-1) and SOCS-3 Cause Insulin Resistance through Inhibition of Tyrosine Phosphorylation of Insulin Receptor Substrate Proteins by Discrete Mechanisms , 2004, Molecular and Cellular Biology.

[247]  C. Kellendonk,et al.  Inactivation of the glucocorticoid receptor in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in streptozotocin-induced diabetes mellitus. , 2004, Molecular endocrinology.

[248]  N. Porksen,et al.  Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors. , 2004, The Journal of clinical investigation.

[249]  F. Wondisford,et al.  Insulin regulation of hepatic gluconeogenesis through phosphorylation of CREB-binding protein , 2004, Nature Medicine.

[250]  Sander M Houten,et al.  Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. , 2004, The Journal of clinical investigation.

[251]  K. Iizuka,et al.  Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[252]  H. Towle,et al.  Mlx Is the Functional Heteromeric Partner of the Carbohydrate Response Element-binding Protein in Glucose Regulation of Lipogenic Enzyme Genes* , 2004, Journal of Biological Chemistry.

[253]  B. Monia,et al.  Reduction in glucagon receptor expression by an antisense oligonucleotide ameliorates diabetic syndrome in db/db mice. , 2004, Diabetes.

[254]  P. Edwards,et al.  Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) regulates triglyceride metabolism by activation of the nuclear receptor FXR , 2004 .

[255]  Y. Kido,et al.  Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo , 2004, Nature Medicine.

[256]  Othon B. Kotoulas,et al.  Glycogen autophagy , 2004, Microscopy research and technique.

[257]  Xianlin Han,et al.  Decreased Hepatic Triglyceride Accumulation and Altered Fatty Acid Uptake in Mice with Deletion of the Liver Fatty Acid-binding Protein Gene* , 2003, Journal of Biological Chemistry.

[258]  Ianessa Morantte,et al.  CREB controls hepatic lipid metabolism through nuclear hormone receptor PPAR-γ , 2003, Nature.

[259]  M. Reitman,et al.  Liver Peroxisome Proliferator-activated Receptor γ Contributes to Hepatic Steatosis, Triglyceride Clearance, and Regulation of Body Fat Mass* , 2003, Journal of Biological Chemistry.

[260]  P. Scherer,et al.  Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/en.2003-0580 Minireview: The Adipocyte—At the Crossroads of Energy Homeostasis, Inflammation, and Atherosclerosis , 2022 .

[261]  Yu Wang,et al.  The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. , 2003, The Journal of clinical investigation.

[262]  B. Atshaves,et al.  Decreased Liver Fatty Acid Binding Capacity and Altered Liver Lipid Distribution in Mice Lacking the Liver Fatty Acid-binding Protein Gene* , 2003, Journal of Biological Chemistry.

[263]  Bruce M. Spiegelman,et al.  Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction , 2003, Nature.

[264]  B. Wadzinski,et al.  Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[265]  Bei B. Zhang,et al.  Glucagon and regulation of glucose metabolism. , 2003, American journal of physiology. Endocrinology and metabolism.

[266]  B. Brewer,et al.  Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. , 2003, The Journal of clinical investigation.

[267]  B. Staels,et al.  Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor. , 2003, Molecular endocrinology.

[268]  J. Holst,et al.  Lower blood glucose, hyperglucagonemia, and pancreatic α cell hyperplasia in glucagon receptor knockout mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[269]  L. Rossetti,et al.  Hypothalamic insulin signaling is required for inhibition of glucose production , 2002, Nature Medicine.

[270]  M. White,et al.  SOCS-1 and SOCS-3 Block Insulin Signaling by Ubiquitin-mediated Degradation of IRS1 and IRS2* , 2002, The Journal of Biological Chemistry.

[271]  S. Uchida,et al.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature Medicine.

[272]  M. White,et al.  IRS proteins and the common path to diabetes. , 2002, American journal of physiology. Endocrinology and metabolism.

[273]  B. Yandell,et al.  Loss of stearoyl–CoA desaturase-1 function protects mice against adiposity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[274]  N. Socci,et al.  Role for Stearoyl-CoA Desaturase-1 in Leptin-Mediated Weight Loss , 2002, Science.

[275]  Zhaohui Feng,et al.  Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats , 2002, Nature Neuroscience.

[276]  Joseph L Goldstein,et al.  SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. , 2002, The Journal of clinical investigation.

[277]  J. Gustafsson,et al.  Liver X Receptors as Insulin-mediating Factors in Fatty Acid and Cholesterol Biosynthesis* , 2002, The Journal of Biological Chemistry.

[278]  Y. Kido,et al.  CEACAM1 regulates insulin clearance in liver , 2002, Nature Genetics.

[279]  Zhaohui Feng,et al.  Central administration of oleic acid inhibits glucose production and food intake. , 2002, Diabetes.

[280]  J. Stock,et al.  Glycemic control in mice with targeted disruption of the glucagon receptor gene. , 2002, Biochemical and biophysical research communications.

[281]  C. Kahn,et al.  Insulin signalling and the regulation of glucose and lipid metabolism , 2001, Nature.

[282]  K. Uyeda,et al.  Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/dephosphorylation of the carbohydrate response element binding protein , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[283]  D. Accili,et al.  The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. , 2001, The Journal of clinical investigation.

[284]  Marc Montminy,et al.  CREB regulates hepatic gluconeogenesis through the coactivator PGC-1 , 2001, Nature.

[285]  Guillaume Adelmant,et al.  Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1 , 2001, Nature.

[286]  M. Sakurai,et al.  A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[287]  G. Shulman,et al.  Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[288]  Martin M. Matzuk,et al.  Continuous Fatty Acid Oxidation and Reduced Fat Storage in Mice Lacking Acetyl-CoA Carboxylase 2 , 2001, Science.

[289]  R. Bartrons,et al.  PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate. , 2001, Trends in biochemical sciences.

[290]  Jean-Marc A. Lobaccaro,et al.  Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ , 2000 .

[291]  D. Mangelsdorf,et al.  Role of LXRs in control of lipogenesis. , 2000, Genes & development.

[292]  Masahiro Tohkin,et al.  Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis , 2000, Cell.

[293]  R. Chalkley,et al.  Phosphoenolpyruvate Carboxykinase Is Necessary for the Integration of Hepatic Energy Metabolism , 2000, Molecular and Cellular Biology.

[294]  C. Kahn,et al.  Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. , 2000, Molecular cell.

[295]  Rick B. Vega,et al.  The Coactivator PGC-1 Cooperates with Peroxisome Proliferator-Activated Receptor α in Transcriptional Control of Nuclear Genes Encoding Mitochondrial Fatty Acid Oxidation Enzymes , 2000, Molecular and Cellular Biology.

[296]  S. Chirala,et al.  The subcellular localization of acetyl-CoA carboxylase 2. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[297]  I. Shimomura,et al.  Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. , 2000, Genes & development.

[298]  D. Kelly,et al.  A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[299]  P. Cohen,et al.  Phosphorylation of Serine 256 by Protein Kinase B Disrupts Transactivation by FKHR and Mediates Effects of Insulin on Insulin-like Growth Factor-binding Protein-1 Promoter Activity through a Conserved Insulin Response Sequence* , 1999, The Journal of Biological Chemistry.

[300]  W. Wahli,et al.  Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting , 1999 .

[301]  S. Vaulont,et al.  Essential Role in Vivo of Upstream Stimulatory Factors for a Normal Dietary Response of the Fatty Acid Synthase Gene in the Liver* , 1999, The Journal of Biological Chemistry.

[302]  V. Poli,et al.  Hypoglycemia and impaired hepatic glucose production in mice with a deletion of the C/EBPbeta gene. , 1999, The Journal of clinical investigation.

[303]  M. Magnuson,et al.  Dual Roles for Glucokinase in Glucose Homeostasis as Determined by Liver and Pancreatic β Cell-specific Gene Knock-outs Using Cre Recombinase* , 1999, The Journal of Biological Chemistry.

[304]  W. Wahli,et al.  Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. , 1999, The Journal of clinical investigation.

[305]  M. Takiguchi,et al.  Hypoglycemia-associated Hyperammonemia Caused by Impaired Expression of Ornithine Cycle Enzyme Genes in C/EBPα Knockout Mice* , 1998, The Journal of Biological Chemistry.

[306]  W. Duckworth,et al.  Insulin degradation: progress and potential. , 1998, Endocrine reviews.

[307]  M. Stumvoll,et al.  Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus. , 1998, The Journal of clinical investigation.

[308]  D. Mangelsdorf,et al.  An oxysterol signalling pathway mediated by the nuclear receptor LXRα , 1996, Nature.

[309]  J. Reddy,et al.  Hepatocellular and Hepatic Peroxisomal Alterations in Mice with a Disrupted Peroxisomal Fatty Acyl-coenzyme A Oxidase Gene* , 1996, The Journal of Biological Chemistry.

[310]  A. Bradley,et al.  Impaired energy homeostasis in C/EBP alpha knockout mice , 1995, Science.

[311]  K. Mikoshiba,et al.  The inositol 1,4,5-trisphosphate receptor. , 1992, Ciba Foundation symposium.

[312]  R. Shulman,et al.  Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. , 1992, The Journal of clinical investigation.

[313]  D. Wasserman,et al.  Glucagon is a primary controller of hepatic glycogenolysis and gluconeogenesis during muscular work. , 1989, The American journal of physiology.

[314]  F. Capani,et al.  Predominant Role of Gluconeogenesis in Increased Hepatic Glucose Production in NIDDM , 1989, Diabetes.